Capital Investment Advisors’s iShares iBonds Dec 2035 Term Corporate ETF IBCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.9M Buy
2,536,059
+250,409
+11% +$6.41M 0.86% 37
2026
Q1
$58.6M Buy
2,285,650
+569,900
+33% +$14.8M 0.86% 37
2025
Q4
$44.5M Buy
1,715,750
+332,225
+24% +$8.65M 0.68% 43
2025
Q3
$36M Buy
1,383,525
+355,569
+35% +$9.13M 0.59% 44
2025
Q2
$26.3M Buy
+1,027,956
New +$25.8M 0.47% 63

Other funds holding IBCA

Capital Investment Advisors's IBCA Position: Q2 2026 in Review

Capital Investment Advisors increased its iShares iBonds Dec 2035 Term Corporate ETF (IBCA) stake by 11% in Q2 2026, buying an estimated $6.41M and bringing the position to 2,536,059 shares worth $64.9M. The position accounts for 0.86% of the portfolio, ranked #37.

Capital Investment Advisors first reported a position in IBCA in Q2 2025 and has held it in 5 quarters since. 93 funds tracked by Wall St. Rank hold IBCA as of Q2 2026.

  • Capital Investment Advisors held 2,536,059 shares of iShares iBonds Dec 2035 Term Corporate ETF worth $64.9M as of Q2 2026.
  • Capital Investment Advisors bought 250,409 iShares iBonds Dec 2035 Term Corporate ETF shares in Q2 2026, an estimated $6.41M.
  • iShares iBonds Dec 2035 Term Corporate ETF made up 0.86% of Capital Investment Advisors's portfolio in Q2 2026, its #37 holding.
  • Capital Investment Advisors first reported a position in iShares iBonds Dec 2035 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • 93 funds tracked by Wall St. Rank held iShares iBonds Dec 2035 Term Corporate ETF as of Q2 2026.

Based on Capital Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.